These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 22008950)

  • 1. Failure of glycated hemoglobin drop after continuous subcutaneous insulin infusion initiation may indicate patients who discontinue: a 4-year follow-up study in children and adolescents with type 1 diabetes.
    Lombardo F; Scaramuzza AE; Iafusco D
    Acta Diabetol; 2012 Dec; 49 Suppl 1():S99-105. PubMed ID: 22008950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HbA
    Evans-Cheung TC; Campbell F; Yong J; Parslow RC; Feltbower RG
    Diabet Med; 2019 Jan; 36(1):88-95. PubMed ID: 30059173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A 7-year follow-up retrospective, international, multicenter study of insulin pump therapy in children and adolescents with type 1 diabetes.
    Mameli C; Scaramuzza AE; Ho J; Cardona-Hernandez R; Suarez-Ortega L; Zuccotti GV
    Acta Diabetol; 2014 Apr; 51(2):205-10. PubMed ID: 23681558
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Three-year comparison of subcutaneous insulin pump treatment with multi-daily injections on HbA1c, its variability and hospital burden of children with type 1 diabetes.
    Fendler W; Baranowska AI; Mianowska B; Szadkowska A; Mlynarski W
    Acta Diabetol; 2012 Oct; 49(5):363-70. PubMed ID: 21964866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the timing of insulin pump therapy initiation after type 1 diabetes onset have an impact on glycemic control?
    Shalitin S; Lahav-Ritte T; Lebenthal Y; Devries L; Phillip M
    Diabetes Technol Ther; 2012 May; 14(5):389-97. PubMed ID: 22283639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effectiveness of Continuous Subcutaneous Insulin Infusion Pump Therapy During Five Years of Treatment on Metabolic Control in Children and Adolescents with Type 1 Diabetes Mellitus.
    Korkmaz Ö; Demir G; Çetin H; Mecidov İ; Atik Altınok Y; Özen S; Darcan Ş; Gökşen D
    J Clin Res Pediatr Endocrinol; 2018 Jun; 10(2):147-152. PubMed ID: 29537377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with adherence to continuous subcutaneous insulin infusion in pediatric diabetes.
    Babar GS; Ali O; Parton EA; Hoffmann RG; Alemzadeh R
    Diabetes Technol Ther; 2009 Mar; 11(3):131-7. PubMed ID: 19216689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Persistence of benefits of continuous subcutaneous insulin infusion in very young children with type 1 diabetes: a follow-up report.
    Weinzimer SA; Ahern JH; Doyle EA; Vincent MR; Dziura J; Steffen AT; Tamborlane WV
    Pediatrics; 2004 Dec; 114(6):1601-5. PubMed ID: 15574621
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Physiological factors influencing diabetes control in type 1 diabetes children with insulin pumps from diagnosis.
    Piechowiak K; Szypowska A
    Diabetes Metab Res Rev; 2019 Jan; 35(1):e3086. PubMed ID: 30325106
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term efficacy of insulin pump therapy on glycemic control in adults with type 1 diabetes mellitus.
    Orr CJ; Hopman W; Yen JL; Houlden RL
    Diabetes Technol Ther; 2015 Jan; 17(1):49-54. PubMed ID: 25317602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous subcutaneous insulin infusion therapy is associated with reduced retinopathy progression compared with multiple daily injections of insulin.
    Reid LJ; Gibb FW; Colhoun H; Wild SH; Strachan MWJ; Madill K; Dhillon B; Forbes S
    Diabetologia; 2021 Aug; 64(8):1725-1736. PubMed ID: 33966091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Continuous subcutaneous insulin infusion versus multiple daily injections in children and young people at diagnosis of type 1 diabetes: the SCIPI RCT.
    Blair J; McKay A; Ridyard C; Thornborough K; Bedson E; Peak M; Didi M; Annan F; Gregory JW; Hughes D; Gamble C
    Health Technol Assess; 2018 Aug; 22(42):1-112. PubMed ID: 30109847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-Term Effects of Continuous Subcutaneous Insulin Infusion on Glucose Control and Microvascular Complications in Patients With Type 1 Diabetes.
    Marchand L; Kawasaki-Ogita Y; Place J; Fayolle C; Lauton D; Boulet F; Farret A; Renard E
    J Diabetes Sci Technol; 2017 Sep; 11(5):924-929. PubMed ID: 28303725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic control in children with diabetes mellitus who are younger than 6 years at diagnosis: continuous subcutaneous insulin infusion as a first line treatment?
    Sulmont V; Souchon PF; Gouillard-Darnaud C; Fartura A; Salmon-Musial AS; Lambrecht E; Mauran P; Abely M
    J Pediatr; 2010 Jul; 157(1):103-7. PubMed ID: 20227730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of social deprivation, demographics and centre on HbA
    Paisley AN; Beynon J; Fullwood C; Hindle A; Alam T; Urwin A; Chapman A; Morris J; Thabit H; Rutter MK; Leelarathna L
    Diabet Med; 2019 Mar; 36(3):383-387. PubMed ID: 30307056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effects of continuous subcutaneous insulin infusion and flexible multiple daily insulin regimen using insulin glargine in type 1 diabetes.
    Alemzadeh R; Ellis JN; Holzum MK; Parton EA; Wyatt DT
    Pediatrics; 2004 Jul; 114(1):e91-5. PubMed ID: 15231979
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in insulin usage patterns with pubertal development in children with type 1 diabetes during transition from multiple daily injections to continuous subcutaneous insulin infusion (CSII) and through the CSII treatment.
    Shashaj B; Sulli N
    Diabetes Technol Ther; 2009 Dec; 11(12):767-74. PubMed ID: 20001677
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proportion of Basal to Total Insulin Dose Is Associated with Metabolic Control, Body Mass Index, and Treatment Modality in Children with Type 1 Diabetes-A Cross-Sectional Study with Data from the International SWEET Registry.
    Rasmussen VF; Vestergaard ET; Schwandt A; Beltrand J; Rami-Merhar B; O'Riordan SMP; Jarosz-Chobot P; Castro-Correia C; Gevers EF; Birkebæk NH
    J Pediatr; 2019 Dec; 215():216-222.e1. PubMed ID: 31345576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Continuous subcutaneous insulin infusion in diabetes mellitus type 1 and 2: lower HbA1c-values and a high level of patient satisfaction].
    de Borst JM; Berghout A
    Ned Tijdschr Geneeskd; 2003 Oct; 147(41):2021-5. PubMed ID: 14587146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Benefits of continuous subcutaneous insulin infusion in children with type 1 diabetes.
    Willi SM; Planton J; Egede L; Schwarz S
    J Pediatr; 2003 Dec; 143(6):796-801. PubMed ID: 14657831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.